12 January 2021 | News
Jain is a well-known veteran in the pharmaceutical industry and brings with him decades of strong leadership and drug policy experience
IGBA, the International Generic and Biosimilar Medicines Association, representing global manufacturers of generic and biosimilar medicines, has announced that Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance (IPA), is taking over the position of IGBA Chair for 2021 from Hanan Sboul, Secretary General of the Jordanian Association of Pharmaceutical Manufacturers.
The incoming IGBA Chair Sudarshan Jain is a well-known veteran in the pharmaceutical industry and brings with him decades of strong leadership and drug policy experience.
“I am very pleased and proud to take over the Chairmanship of IGBA and look forward to ensuring that IGBA continues to expand its outreach relevant to its mission, priorities and operations,” commented Jain.
“More than ever, we need to transform the lessons learned from the current pandemic and public health crises into resilience of the supply-chain of Active Pharmaceutical Ingredients (APIs) and Finished Products (FPs) and ensure that the needs of patients and their access to affordable, safe, and effective generic and biosimilar medicines are taken into account in trade agreements,” concluded Jain.